Tau Subtypes of Alzheimer's Disease Determined in vivo Using Flortaucipir PET Imaging

被引:24
|
作者
Charil, Arnaud [1 ]
Shcherbinin, Sergey [1 ]
Southekal, Sudeepti [5 ]
Devous, Michael D. [5 ]
Mintun, Mark [1 ,5 ]
Murray, Melissa E. [4 ]
Miller, Bradley B. [1 ]
Schwarz, Adam J. [1 ,2 ,3 ]
机构
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA
[3] Indiana Univ, Dept Radiol & Imaging Sci, Indianapolis, IN 46204 USA
[4] Mayo Clin, Jacksonville, FL 32224 USA
[5] Avid Radiopharmaceut, Philadelphia, PA USA
关键词
Hippocampal sparing; limbic predominant; subtype; tau; NEUROPATHOLOGICALLY DEFINED SUBTYPES; MILD COGNITIVE IMPAIRMENT; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; ATROPHY; F-18-AV-1451; PATHOLOGY; RECOMMENDATIONS; PATTERNS;
D O I
10.3233/JAD-190264
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
At autopsy, individuals with Alzheimer's disease (AD) exhibit heterogeneity in the distribution of neurofibrillary tangles in neocortical and hippocampal regions. Subtypes of AD, defined using an algorithm based on the relative number of tangle counts in these regions, have been proposed-hippocampal sparing (relative sparing of the hippocampus but high cortical load), limbic predominant (high hippocampal load but lower load in association cortices), and typical (balanced neurofibrillary tangles counts in the hippocampus and association cortices) AD-and shown to be associated with distinct antemortem clinical phenotypes. The ability to distinguish these AD subtypes from the more typical tau signature in vivo could have important implications for clinical research. Flortaucipir positron emission tomography (PET) images acquired from 45 amyloid-positive participants, defined clinically as mild cognitive impairment or AD, aged 50-92 years, 56% female, and estimated to be Braak V-VI based on their PET pattern of tau pathology, were studied. By translating the neuropathologic algorithm to flortaucipir PET scans, patterns of tau pathology consistent with autopsy findings, and with a similar prevalence, were identified in vivo. 6/45 (13%) participants were identified as hippocampal sparing and 6/45 (13%) as limbic predominant AD subtypes. Hippocampal sparing participants were significantly younger than those assigned to the other two subtypes. Worse performance on delayed recall was associated with increased hippocampal tau signal, and worse performance on the trail making test B-A was associated with lower values of the hippocampus to cortex ratio. Prospective studies can further validate the flortaucipir SUVR cut-points and the phenotype of the corresponding AD subtypes.
引用
收藏
页码:1037 / 1048
页数:12
相关论文
共 50 条
  • [41] Comparison of Two Analytical Platforms in Cerebrospinal Fluid Biomarkers for the Classification of Alzheimer's Disease Spectrum with Amyloid PET Imaging
    Lim, Ho Jae
    Park, Jung Eun
    Kim, Byeong C.
    Choi, Seong-Min
    Song, Min-Kyung
    Cho, Soo Hyun
    Seo, Hyeon Jeong
    Kim, Jahae
    Song, Ho-Chun
    Choi, Kyu Yeong
    Lee, Jang Jae
    Kim, Hoo-Won
    Ha, Jung-Min
    Song, Woo Keun
    Park, Sung-Gyoo
    Lee, Jung Sup
    Lee, Kun Ho
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 75 (03) : 949 - 958
  • [42] Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease
    Emma E. Wolters
    Rik Ossenkoppele
    Sander C. J. Verfaillie
    Emma M. Coomans
    Tessa Timmers
    Denise Visser
    Hayel Tuncel
    Sandeep S. V. Golla
    Albert D. Windhorst
    Ronald Boellaard
    Wiesje M. van der Flier
    Charlotte E. Teunissen
    Philip Scheltens
    Bart N. M. van Berckel
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 2866 - 2878
  • [43] Performance of a [18F]Flortaucipir PET Visual Read Method Across the Alzheimer Disease Continuum and in Dementia With Lewy Bodies
    Coomans, Emma M.
    de Koning, Lotte A.
    Rikken, Roos M.
    Verfaillie, Sander C. J.
    Visser, Denise
    den Braber, Anouk
    Tomassen, Jori
    van de Beek, Marleen
    Collij, Lyduine E.
    Lemstra, Afina W.
    Windhorst, Albert D.
    Barkhof, Frederik
    Golla, Sandeep S. V.
    Visser, Pieter Jelle
    Scheltens, Philip
    van der Flier, Wiesje M.
    Ossenkoppele, Rik
    van Berckel, Bart N. M.
    van de Giessen, Elsmarieke
    NEUROLOGY, 2023, 101 (19) : E1850 - E1862
  • [44] Association of in vivo retention of [18f] flortaucipir pet with tau neuropathology in corresponding brain regions
    Freiburghaus, Tove
    Pawlik, Daria
    Oliveira Hauer, Kevin
    Ossenkoppele, Rik
    Strandberg, Olof
    Leuzy, Antoine
    Rittmo, Jonathan
    Tremblay, Cecilia
    Serrano, Geidy E.
    Pontecorvo, Michael J.
    Beach, Thomas G.
    Smith, Ruben
    Hansson, Oskar
    ACTA NEUROPATHOLOGICA, 2024, 148 (01)
  • [45] In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease
    Villemagne, Victor L.
    Furumoto, Shozo
    Fodero-Tavoletti, Michelle T.
    Mulligan, Rachel S.
    Hodges, John
    Harada, Ryuichi
    Yates, Paul
    Piguet, Olivier
    Pejoska, Svetlana
    Dore, Vincent
    Yanai, Kazuhiko
    Masters, Colin L.
    Kudo, Yukitsuka
    Rowe, Christopher C.
    Okamura, Nobuyuki
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (05) : 816 - 826
  • [46] PET Imaging of Tau Pathology and Amyloid-β, and MRI for Alzheimer's Disease Feature Fusion and Multimodal Classification
    Shojaie, Mehdi
    Tabarestani, Solale
    Cabrerizo, Mercedes
    DeKosky, Steven T.
    Vaillancourt, David E.
    Loewenstein, David
    Duara, Ranjan
    Adjouadi, Malek
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 84 (04) : 1497 - 1514
  • [47] Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer's disease
    Teng, Edmond
    Manser, Paul T.
    Bohorquez, Sandra Sanabria
    Wildsmith, Kristin R.
    Pickthorn, Karen
    Baker, Suzanne L.
    Ward, Michael
    Kerchner, Geoffrey A.
    Weimer, Robby M.
    ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)
  • [48] Towards clinical application of tau PET tracers for diagnosing dementia due to Alzheimer's disease
    Ossenkoppele, Rik
    Hansson, Oskar
    ALZHEIMERS & DEMENTIA, 2021, 17 (12) : 1998 - 2008
  • [49] Comparison of regional flortaucipir PET with quantitative tau immunohistochemistry in three subjects with Alzheimer’s disease pathology: a clinicopathological study
    Michael J. Pontecorvo
    C. Dirk Keene
    Thomas G. Beach
    Thomas J. Montine
    Anupa K. Arora
    Michael D. Devous
    Michael Navitsky
    Ian Kennedy
    Abhinay D. Joshi
    Ming Lu
    Geidy E. Serrano
    Lucia I. Sue
    Anthony J. Intorcia
    Shannon E. Rose
    Angela Wilson
    Leanne Hellstern
    Natalie Coleman
    Matthew Flitter
    Patricia Aldea
    Adam S. Fleisher
    Mark A. Mintun
    Andrew Siderowf
    EJNMMI Research, 10
  • [50] Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm
    Konstantinos Chiotis
    Laure Saint-Aubert
    Irina Savitcheva
    Vesna Jelic
    Pia Andersen
    My Jonasson
    Jonas Eriksson
    Mark Lubberink
    Ove Almkvist
    Anders Wall
    Gunnar Antoni
    Agneta Nordberg
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 1686 - 1699